Publication:
Chronic kidney disease as cardiovascular risk factor in routine clinical practice: A position statement by the Council of the European Renal Association

dc.contributor.authorTUĞLULAR, ZÜBEYDE SERHAN
dc.contributor.authorsOrtiz A., Wanner C., Gansevoort R., Council E.
dc.date.accessioned2023-05-18T05:45:58Z
dc.date.available2023-05-18T05:45:58Z
dc.date.issued2023-02-01
dc.description.abstractThe European Society of Cardiology 2021 guideline on cardiovascular (CV) disease (CVD) prevention in clinical practice has major implications for both CV risk screening and kidney health of interest to primary care physicians, cardiologists, nephrologists, and other professionals involved in CVD prevention. The proposed CVD prevention strategies require as first step the categorization of individuals into those with established atherosclerotic CVD, diabetes, familiar hypercholesterolaemia, or chronic kidney disease (CKD), i.e. conditions that are already associated with a moderate to very-high CVD risk. This places CKD, defined as decreased kidney function or increased albuminuria as a starting step for CVD risk assessment. Thus, for adequate CVD risk assessment, patients with diabetes, familiar hypercholesterolaemia, or CKD should be identified by an initial laboratory assessment that requires not only serum to assess glucose, cholesterol, and creatinine to estimate the glomerular filtration rate, but also urine to assess albuminuria. The addition of albuminuria as an entry-level step in CVD risk assessment should change clinical practice as it differs from the current healthcare situation in which albuminuria is only assessed in persons already considered to be at high risk of CVD. A diagnosis of moderate of severe CKD requires a specific set of interventions to prevent CVD. Further research should address the optimal method for CV risk assessment that includes CKD assessment in the general population, i.e. whether this should remain opportunistic screening or whether systematic screening.
dc.identifier.citationOrtiz A., Wanner C., Gansevoort R., Council E., "Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association", CLINICAL KIDNEY JOURNAL, cilt.16, sa.3, ss.403-407, 2023
dc.identifier.doi10.1093/ckj/sfac199
dc.identifier.endpage407
dc.identifier.issn2048-8505
dc.identifier.issue3
dc.identifier.startpage403
dc.identifier.urihttps://avesis.marmara.edu.tr/api/publication/6fcbbe3f-a148-4d80-9dfb-1ff220659c8b/file
dc.identifier.urihttps://hdl.handle.net/11424/289436
dc.identifier.volume16
dc.language.isoeng
dc.relation.ispartofCLINICAL KIDNEY JOURNAL
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectTıp
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectNefroloji
dc.subjectSağlık Bilimleri
dc.subjectMedicine
dc.subjectInternal Medicine Sciences
dc.subjectInternal Diseases
dc.subjectNephrology
dc.subjectHealth Sciences
dc.subjectÜROLOJİ VE NEFROLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectUROLOGY & NEPHROLOGY
dc.subjectCLINICAL MEDICINE
dc.subjectClinical Medicine (MED)
dc.subjectÜroloji
dc.subjectUrology
dc.subjectGFR
dc.subjectalbuminuria
dc.subjectcardiovascular risk
dc.subjectrisk prediction
dc.subjectprevention
dc.subjectSOCIETY
dc.subjectGFR
dc.subjectalbuminuria
dc.subjectcardiovascular risk
dc.subjectrisk prediction
dc.subjectprevention
dc.titleChronic kidney disease as cardiovascular risk factor in routine clinical practice: A position statement by the Council of the European Renal Association
dc.typearticle
dspace.entity.typePublication
local.avesis.id6fcbbe3f-a148-4d80-9dfb-1ff220659c8b
local.indexed.atWOS
local.indexed.atPUBMED
local.indexed.atSCOPUS
relation.isAuthorOfPublication3ea0c6f9-3408-46b6-b382-144ccbf7bc72
relation.isAuthorOfPublication.latestForDiscovery3ea0c6f9-3408-46b6-b382-144ccbf7bc72

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
1.pdf
Size:
343.98 KB
Format:
Adobe Portable Document Format

Collections